Literature DB >> 6682501

Guillain-Barré syndrome in the United States, 1978-1981: additional observations from the national surveillance system.

J E Kaplan, L B Schonberger, E S Hurwitz, P Katona.   

Abstract

During the period January 1978-March 1981, 2,575 cases of Guillain-Barré syndrome (GBS) were reported by participating neurologists in the national GBS surveillance system. The incidence of GBS was highest in the 50- to 74-year-old age group, but a lesser peak was observed in persons aged 15 to 35. The frequencies of antecedent respiratory (43%) and gastrointestinal (21%) illness exceeded frequencies of such illnesses in the US population (10 and 0.8%, respectively), based on survey data compiled by the National Center for Health Statistics; the differences in these frequencies of illness were similar in all seasons of the year, in males and in females, and in persons less than 6, 6 to 16, 17 to 44, and greater than 44 years of age. Nineteen percent of adult patients for whom information was available (67% of the total) reported receiving an A/New Jersey influenza vaccine in 1976, a lower percentage than would be expected on the basis of a survey conducted in that year. The data suggest that persons who received this vaccine have not been at increased risk and may even have been at decreased risk of acquiring GBS during the period covered by this study.

Entities:  

Mesh:

Year:  1983        PMID: 6682501     DOI: 10.1212/wnl.33.5.633

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  11 in total

1.  "Prepandemic" immunization for novel influenza viruses, "swine flu" vaccine, Guillain-Barré syndrome, and the detection of rare severe adverse events.

Authors:  David Evans; Simon Cauchemez; Frederick G Hayden
Journal:  J Infect Dis       Date:  2009-08-01       Impact factor: 5.226

2.  Guillain-Barré syndrome in Stockholm County, 1973-1991.

Authors:  G X Jiang; Q Cheng; A Ehrnst; H Link; J de Pedro-Cuesta
Journal:  Eur J Epidemiol       Date:  1997-01       Impact factor: 8.082

3.  Epidemiological features of Guillain-Barré syndrome in Sweden, 1978-93.

Authors:  G X Jiang; Q Cheng; H Link; J de Pedro-Cuesta
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-05       Impact factor: 10.154

4.  Epidemiology of peripheral neuropathy.

Authors:  C N Martyn; R A Hughes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-04       Impact factor: 10.154

5.  A prospective study of acute idiopathic neuropathy II antecedent events.

Authors:  G L Mancardi; M Del Sette; A Primavera; M Farinelli; D Fumarola
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-03       Impact factor: 10.154

6.  Epidemiology of Campylobacter jejuni isolated from patients with Guillain-Barré and Fisher syndromes in Japan.

Authors:  Masaki Takahashi; Michiaki Koga; Keiko Yokoyama; Nobuhiro Yuki
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

7.  Risk of Guillain-Barré syndrome following herpes zoster, United States, 2010-2018.

Authors:  Tara C Anderson; Jessica W Leung; Rafael Harpaz; Kathleen L Dooling
Journal:  Hum Vaccin Immunother       Date:  2021-12-02       Impact factor: 3.452

8.  Guillain-Barré syndrome and antecedent cytomegalovirus infection, USA 2009-2015.

Authors:  Jessica Leung; James J Sejvar; Jesus Soares; Tatiana M Lanzieri
Journal:  Neurol Sci       Date:  2019-12-11       Impact factor: 3.307

9.  Weakness and the inability to ambulate in a 14-month-old female: a case report and concise review of guillain-barre syndrome.

Authors:  Scott A Bloch; Mahsa Akhavan; Jahn Avarello
Journal:  Case Rep Emerg Med       Date:  2013-01-30

10.  No evidence of a link between influenza vaccines and Guillain-Barre syndrome-associated antiganglioside antibodies.

Authors:  David J Wang; David A Boltz; Janet McElhaney; Jonathan A McCullers; Richard J Webby; Robert G Webster
Journal:  Influenza Other Respir Viruses       Date:  2011-09-29       Impact factor: 4.380

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.